TREATMENT OUTCOMES Sample Clauses

TREATMENT OUTCOMES. I understand that the practice and my treating dentist cannot guarantee treatment outcomes. I am responsible for reviewing the treatment plan and asking any questions I may have prior to receiving treatment. I have the right to accept or reject treatment recommended by my treating dentist. By consenting to my dentist’s treatment plans, I acknowledge that I accept known risks and complications of such treatments. It is my responsibility to fully inform the dentist of my medical history, all medications or other drugs that I am using and otherwise truthfully answer all questions related to my care. It is also my responsibility to follow my dentist’s pre- and post-treatment instructions and oral care instructions. I acknowledge that failure to comply with these requirements may increase the chance of poor treatment outcomes.
AutoNDA by SimpleDocs
TREATMENT OUTCOMES. Although Services can help patients meet their treatment goals, there is no guarantee that this will occur, and, in fact, Patient’s symptoms might initially worsen before improving.
TREATMENT OUTCOMES. At Xxxx Xxxxxxx Dermatology and Xxxx Xxxxxxx Dermatology Affiliate locations we take great efforts to be honest in all of the interactions with you as our valued patient. Aesthetics is not an exact science, and patient outcomes vary from patientto patient, and results are based solely on your individual response to the treatment(s). As it is not possible to predict or guarantee results, any payments made are for treatments performed, not for the specific result desired.
TREATMENT OUTCOMES. When examining the association between acquired resistance to streptomycin or ethionamide and clinically relevant treatment outcomes, we focused our analysis on subjects who had good or poor outcomes and excluded those who were lost to follow-up and those whose strains were resistant at baseline (n = 546 total excluded for streptomycin, n = 375 total excluded for ethionamide). Streptomycin Of the 42 subjects whose strains developed resistance to streptomycin, n = 15 (35.7%) were excluded because they were lost to follow up. Among the remaining 27 subjects whose strains acquired resistance to streptomycin, 10 (37.0%) had poor treatment outcomes, compared to 56 (19.6%) of the 286 subjects whose strains did not acquire this resistance (crude OR 2.42, 95% CI 1.05 – 5.56, p = 0.03) (Table 4). Of the 24 risk factors mentioned previously, three were found to be confounding variables in the logistic regression model for streptomycin. These factors were: previous treatment with second-line injectable drugs, HIV status, and number of effective drugs being used to treat the current MDR TB infection. Controlling for these factors with multivariable logistic regression model, we found that subjects whose strains developed resistance to streptomycin had 35% greater odds of having poor treatment outcomes than those who remained susceptible, although this was not statistically significant (adjusted OR = 1.35, 95% CI 0.86 – 2.11, p = 0.20).
TREATMENT OUTCOMES. Although Services can help patients meet their treatment goals, there is no guarantee that this will occur, and, in fact, Patient’s symptoms might initially worsen before improving. Patient’s Responsibilities. Patient shall be responsible for performing the following obligations so long as Patient remains a patient of KBFTT: As compensation for the Services performed by KBFTT, prior to the commencement of each session, Patient shall pay KBFTT $225 per fifty-minute session throughout the term of this Agreement. Since KBFTT does not accept insurance, it is Patient’s responsibility to submit claims for reimbursement to Patient’s insurance company, and to follow up on the status of any claims submitted. Patient will be honest with his/her Psychotherapist about his/her thoughts and feelings, and Patient will comply with the treatment plan, including completing any outside of session “homework” assignments, as established by Patient’s Psychotherapist. Patient shall conduct himself/herself in an honest, appropriate, and lawful manner when interacting with Psychotherapist and other members of KBFTT’s staff.
TREATMENT OUTCOMES. At Xxxx Xxxxxxx Dermatology and Xxxx Xxxxxxx Dermatology Affiliate locations we take great efforts to be honest in all of the interactions with you as our valued patient. Aesthetics is not an exact science, and patient outcomes vary from patient to patient, and results are based solely on your individual response to the treatment(s). As it is not possible to predict or guarantee results, any payments made are for treatments performed, not for the specific result desired. *ADDITIONAL SITE SPECIFIC CONSIDERATIONS (XXXX VALLEY, MD) -50% Deposit is due upon scheduling your appointment. The balance will be due on date of service, prior to treatment. -Ulthera/Thermage: 20% of the total fee is nonrefundable if the appointment is canceled with less than ONE WEEK of notice. -Sculptra: Full deposit is required. Nonrefundable if the appointment is canceled with less than ONE WEEK of notice. -Other procedures: 20% of the total fee is nonrefundable if the appointment is canceled with less ONE WEEK of notice. *Additional site locations and/or offices may have additional considerations or policies that may not be indicated by this form. Please ask your site location if there are any of these instances.
TREATMENT OUTCOMES. I understand that the practice and my treating provider cannot guarantee treatment outcomes. I am responsible for reviewing the treatment plan and asking any questions I may have prior to receiving treatment. I have the right to accept or reject treatment recommended by my treating provider. By consenting to my provider's treatment plans, I acknowledge that I accept known risks and complications of such treatments. It is my responsibility to fully inform the provider of my medical history, all medications or other drugs that I am using and otherwise truthfully answer all questions related to my care. It is also my responsibility to follow my provider's pre- and post-treatment instructions. I acknowledge that failure to comply with these requirements may increase the chance of poor outcomes.
AutoNDA by SimpleDocs

Related to TREATMENT OUTCOMES

  • Future Treatment of Unallowable Costs Unallowable Costs shall be separately determined and accounted for by Defendants, and Defendants shall not charge such Unallowable Costs directly or indirectly to any contracts with the United States or any State Medicaid program, or seek payment for such Unallowable Costs through any cost report, cost statement, information statement, or payment request submitted by Defendants or any of their subsidiaries or affiliates to the Medicare, Medicaid, TRICARE, or FEHBP Programs.

  • Outcomes Secondary: Career pathway students will: have career goals designated on SEOP, earn concurrent college credit while in high school, achieve a state competency certificate and while completing high school graduation requirements.

  • Treatment The Asset Representations Reviewer agrees to hold and treat Confidential Information given to it under this Agreement in confidence and under the terms and conditions of this Section 4.08, and will implement and maintain safeguards to further assure the confidentiality of the Confidential Information. The Confidential Information will not, without the prior consent of the Issuer and the Servicer, be disclosed or used by the Asset Representations Reviewer, or its officers, directors, employees, agents, representatives or affiliates, including legal counsel (collectively, the “Information Recipients”) other than for the purposes of performing Reviews of Review Receivables or performing its obligations under this Agreement. The Asset Representations Reviewer agrees that it will not, and will cause its Affiliates to not (i) purchase or sell securities issued by the Seller or its Affiliates or special purpose entities on the basis of Confidential Information or (ii) use the Confidential Information for the preparation of research reports, newsletters or other publications or similar communications.

  • RECOGNITION OUTCOMES The receiving institution commits to provide the sending institution and the student with a Transcript of Records within a period stipulated in the inter-institutional agreement and normally not longer than five weeks after publication/proclamation of the student’s results at the receiving institution. The Transcript of Records from the receiving institution will contain at least the minimum information requested in this Learning Agreement template. Table E (or the representation that the institution makes of it) will include all the educational components agreed in table A and, if there were changes to the study programme abroad, in table C. In addition, grade distribution information should be included in the Transcript of Records or attached to it (a web link where this information can be found is enough). The actual start and end dates of the study period will be included according to the following definitions: The start date of the study period is the first day the student has been present at the receiving institution, for example, for the first course, for a welcoming event organised by the host institution or for language and intercultural courses. The end date of the study period is the last day the student has been present at the receiving institution and not his actual date of departure. This is, for example, the end of exams period, courses or mandatory sitting period. Following the receipt of the Transcript of Records from the receiving institution, the sending institution commits to provide to the student a Transcript of Records, without further requirements from the student, and normally within five weeks. The sending institution's Transcript of Records must include at least the information listed in table F (the recognition outcomes) and attach the receiving institution's Transcript of Record. In case of mobility windows, table F may be completed as follows: Component code (if any) Title of recognised component (as indicated in the course catalogue) at the sending institution Number of ECTS credits Sending institution grade, if applicable Mobility window Total: 30 ….. Where applicable, the sending institution will translate the grades received by the student abroad, taking into account the grade distribution information from the receiving institution (see the methodology described in the ECTS Users' Guide). In addition, all the educational components will appear as well in the student's Diploma Supplement. The exact titles from the receiving institution will also be included in the Transcript of Records that is attached to the Diploma Supplement. Steps to fill in the Learning Agreement for Studies P Additional educational components above the number of ECTS credits required in his/her curriculum are listed in the LA and if the sending institution will not recognise them as counting towards their degree, this has to be agreed by all parties concerned and annexed to the LA

  • Medical Treatment Undersigned understands that the Released Parties do not have medical personnel available at the location of the activities. Undersigned hereby grants the Released Parties permission to administer first aid or to authorize emergency medical treatment, if necessary. Undersigned understands and agrees that any such action by the Released Parties shall be subject to the terms of this agreement and release, including any liability arising from the negligence of the Released Parties when administering first aid or authorizing others to do so. Undersigned understands and agrees that the Released Parties do not assume responsibility for any injury or damage which might arise out of or in connection with such authorized emergency medical treatment.

  • Emergency Medical Treatment I grant the Releasees permission to authorize emergency medical treatment as they deem appropriate, and agree that such action by the Releasees shall be subject to the terms of this Agreement. I understand and agree that the Releasees assume no responsibility for any injury or damage that might result from such emergency medical treatment.

  • MANAGEMENT OF EVALUATION OUTCOMES 12.1 The evaluation of the Employee’s performance will form the basis for rewarding outstanding performance or correcting unacceptable performance.

  • Treatment Program Testing The Employer may request or require an employee to undergo drug and alcohol testing if the employee has been referred by the employer for chemical dependency treatment or evaluation or is participating in a chemical dependency treatment program under an employee benefit plan, in which case the employee may be requested or required to undergo drug or alcohol testing without prior notice during the evaluation or treatment period and for a period of up to two years following completion of any prescribed chemical dependency treatment program.

  • Substance Abuse Treatment Information Substance abuse treatment information shall be maintained in compliance with 42 C.F.R. Part 2 if the Party or subcontractor(s) are Part 2 covered programs, or if substance abuse treatment information is received from a Part 2 covered program by the Party or subcontractor(s).

  • TREATMENT PLANS Within a reasonable period of time after the initiation of treatment, Xxxxxxxxx Xxxxx will discuss with you her working understanding of the problem, treatment plan, therapeutic objectives, and her view of the possible outcomes of treatment. If you have any unanswered questions about any of the procedures used in the course of your therapy, their possible risks, Xxxxxxxxx Xxxxx 's expertise in employing them, or about the treatment plan, please ask and you will be answered fully. You also have the right to ask about other treatments for your condition and their risks and benefits.

Time is Money Join Law Insider Premium to draft better contracts faster.